NO20016224L - Farmasöytisk blanding inneholdende sibutramin og orlistat - Google Patents

Farmasöytisk blanding inneholdende sibutramin og orlistat

Info

Publication number
NO20016224L
NO20016224L NO20016224A NO20016224A NO20016224L NO 20016224 L NO20016224 L NO 20016224L NO 20016224 A NO20016224 A NO 20016224A NO 20016224 A NO20016224 A NO 20016224A NO 20016224 L NO20016224 L NO 20016224L
Authority
NO
Norway
Prior art keywords
orlistat
pharmaceutical composition
composition containing
containing sibutramine
sibutramine
Prior art date
Application number
NO20016224A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016224D0 (no
Inventor
David John Heal
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of NO20016224D0 publication Critical patent/NO20016224D0/no
Publication of NO20016224L publication Critical patent/NO20016224L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20016224A 1999-06-24 2001-12-19 Farmasöytisk blanding inneholdende sibutramin og orlistat NO20016224L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9914744.9A GB9914744D0 (en) 1999-06-24 1999-06-24 Therapeutic agents
PCT/EP2000/005542 WO2001000205A1 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and orlistat

Publications (2)

Publication Number Publication Date
NO20016224D0 NO20016224D0 (no) 2001-12-19
NO20016224L true NO20016224L (no) 2002-02-12

Family

ID=10855955

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016224A NO20016224L (no) 1999-06-24 2001-12-19 Farmasöytisk blanding inneholdende sibutramin og orlistat

Country Status (21)

Country Link
EP (1) EP1187606A1 (xx)
JP (1) JP2003503349A (xx)
KR (1) KR20020015357A (xx)
CN (1) CN1358092A (xx)
AU (1) AU5533200A (xx)
BG (1) BG106180A (xx)
BR (1) BR0011880A (xx)
CA (1) CA2375972A1 (xx)
CZ (1) CZ20014613A3 (xx)
GB (1) GB9914744D0 (xx)
HK (1) HK1049278A1 (xx)
HU (1) HUP0201878A3 (xx)
IL (1) IL147079A0 (xx)
MX (1) MXPA01012936A (xx)
NO (1) NO20016224L (xx)
PL (1) PL352402A1 (xx)
RU (1) RU2229289C2 (xx)
SK (1) SK18242001A3 (xx)
TR (1) TR200103699T2 (xx)
WO (1) WO2001000205A1 (xx)
ZA (1) ZA200109989B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696495B2 (en) * 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
US20040214804A1 (en) * 2003-04-25 2004-10-28 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-obesity agent
CA2585175A1 (en) 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions
JP2010503709A (ja) * 2006-09-15 2010-02-04 レビバ ファーマシューティカルズ，インコーポレーテッド シクロアルキルメチルアミンの合成、使用方法および組成物
BRPI0716002A2 (pt) * 2006-11-22 2013-07-30 Sk Chemicals Co Ltd complexo de inclusço, processo de preparaÇço de um complexo de inclusço e composiÇço de tratamento e prevenÇço de hipocondria e obesidade
CN101890017A (zh) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 含有西布曲明和他汀类降脂药物的药物组合物及其用途
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
MX336980B (es) * 2010-12-21 2016-02-09 Senosiain S A De C V Lab Combinacion y composicion para el tratamiento de obesidad.
US9238625B2 (en) 2011-12-30 2016-01-19 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9727131D0 (en) * 1997-12-24 1998-02-25 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
PL352402A1 (en) 2003-08-25
HUP0201878A3 (en) 2005-04-28
RU2229289C2 (ru) 2004-05-27
CZ20014613A3 (cs) 2003-04-16
NO20016224D0 (no) 2001-12-19
ZA200109989B (en) 2003-02-26
AU5533200A (en) 2001-01-31
BR0011880A (pt) 2002-03-19
HK1049278A1 (zh) 2003-05-09
TR200103699T2 (tr) 2002-04-22
IL147079A0 (en) 2002-08-14
MXPA01012936A (es) 2004-04-21
GB9914744D0 (en) 1999-08-25
SK18242001A3 (sk) 2003-02-04
WO2001000205A1 (en) 2001-01-04
EP1187606A1 (en) 2002-03-20
JP2003503349A (ja) 2003-01-28
BG106180A (en) 2002-08-30
KR20020015357A (ko) 2002-02-27
CN1358092A (zh) 2002-07-10
HUP0201878A2 (hu) 2003-08-28
CA2375972A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
NO20001651D0 (no) Nedlasting av data
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
DK1112174T3 (da) Isosorbidholdige polyestere og fremgangsmåder til fremstiling heraf
DE69840172D1 (de) Rna exportelement
NO20032753L (no) Forbindelse og anvendelse derav
DE69839157D1 (de) Fullurene enthaltendes katherdersystem
DE69805692D1 (de) Uhrenarmband
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
FI972461A (fi) Radiojärjestelmä
PT1034144E (pt) Vidro protegido
DK1300129T3 (da) Implantathætteglas
NO20000057L (no) Kjernerør
PT869121E (pt) Derivados de propanolamina hipolipidemicos
DE69935609D1 (de) Formulierungen enthaltend cefuroxim-axetil
DE19882595T1 (de) Schmuckstück
DE59806331D1 (de) Hohlschmuck
NO20016224L (no) Farmasöytisk blanding inneholdende sibutramin og orlistat
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
FI102647B (fi) Ohjelmoitava vahvistin
DE19881428D2 (de) Lustiges Gyros-Spielzeug
DE59813009D1 (de) Funkgerät
ID20194A (id) Penyemprot tegak atau terbalik
KR980000831U (ko) 팔찌
KR960036347U (ko) 팔찌

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application